Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Journal of Medicinal Chemistry
|
May 23, 2000
Modeling of the inhibition of retroviral integrases by styrylquinoline derivatives
M Ouali, C Laboulais, H Leh, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
January 11, 2016
[Value of neck dissection before definitive radiation therapy for locoregionally advanced squamous cell carcinoma of the head and neck]
A Modesto, J Sarini, A Benlyazid, et al.
Acta Biochimica Polonica
|
August 29, 2000
Tautomers of styrylquinoline derivatives containing a methoxy substituent: computation of their population in aqueous solution and their interaction with RSV integrase catalytic core
M Ouali, C Laboulais, H Leh, et al.
British Journal of Cancer
|
April 21, 2011
Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study
N Penel, M V Glabbeke, S Mathoulin-Pelissier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 25, 2015
First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)†
A Ravaud, S Oudard, M De Fromont, et al.
BMC Cancer
|
October 17, 2015
Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group
J Khalifa, M Ouali, L Chaltiel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 2013
Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998)
R B Keus, R A Nout, J-Y Blay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 13, 2013
Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study
H Gelderblom, J Y Blay, B M Seddon, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 11, 2014
Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group
A T Falk, L Moureau-Zabotto, M Ouali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2014
Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials
A Le Cesne, M Ouali, M G Leahy, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Journal of Medicinal Chemistry
|
May 23, 2000
Modeling of the inhibition of retroviral integrases by styrylquinoline derivatives
M Ouali, C Laboulais, H Leh, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
January 11, 2016
[Value of neck dissection before definitive radiation therapy for locoregionally advanced squamous cell carcinoma of the head and neck]
A Modesto, J Sarini, A Benlyazid, et al.
Acta Biochimica Polonica
|
August 29, 2000
Tautomers of styrylquinoline derivatives containing a methoxy substituent: computation of their population in aqueous solution and their interaction with RSV integrase catalytic core
M Ouali, C Laboulais, H Leh, et al.
British Journal of Cancer
|
April 21, 2011
Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study
N Penel, M V Glabbeke, S Mathoulin-Pelissier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 25, 2015
First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)†
A Ravaud, S Oudard, M De Fromont, et al.
BMC Cancer
|
October 17, 2015
Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group
J Khalifa, M Ouali, L Chaltiel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 2013
Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998)
R B Keus, R A Nout, J-Y Blay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 13, 2013
Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study
H Gelderblom, J Y Blay, B M Seddon, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 11, 2014
Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group
A T Falk, L Moureau-Zabotto, M Ouali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2014
Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials
A Le Cesne, M Ouali, M G Leahy, et al.
Page
of 5